BioCentury | Jul 28, 2020
Emerging Company Profile

Frazier, Marcadia founders reunite for rare endocrine diseases in MBX’s $34.6M A round

...diseases company that DiMarchi co-founded, for undisclosed sums. Other companies the two separately co-founded include Assembly Biosciences Inc....
BioCentury | Jul 20, 2020
Deals

Putting cash to work, BeiGene taps Assembly’s HBV program for first non-oncology deal

...through a deal with Assembly that gives it territorial rights to three clinical HBV programs. Assembly Biosciences Inc....
...added $5.28 to $253.95. Targets PARP-1 - Poly(ADP-ribose) polymerase-1 PARP-2 - Poly(ADP-ribose) polymerase-2 Paul Bonanos, Associate Editor ABI-H0731 ABI-H2158 ABI-H3733 Assembly Biosciences Inc. BeiGene...
BioCentury | Jun 23, 2020
Product Development

June 22 Quick Takes: Invitae acquiring ArcherDX; plus lymphoma approval for Karyopharm, Merck, Nabriva, Myovant, Assembly-AbbVie, Genentech and more

...PDUFA date for the GNRHR antagonist is Dec. 20. AbbVie ends microbiome deal with Assembly Assembly Biosciences Inc....
...#), REGN668 (Compound #), dupilumab (Generic), Dupixent (Informal) Merck & Co. Inc. Nabriva Therapeutics AG Myovant Sciences GmbH AbbVie Inc. Assembly Biosciences Inc. Genentech...
BioCentury | May 29, 2020
Management Tracks

Delaney takes over as Assembly’s CSO; plus NGM, TCR2, Amunix, Evox, Vor and more

...as EVP and CFO. She was SVP and CFO of Pfenex Inc. (NYSE-A:PFNX). Robin Sawka, Staff Writer Assembly Biosciences Inc. NGM...
BioCentury | Apr 4, 2020
Management Tracks

CureVac names Stéphenne chairman; plus Desmond-Hellmann to Pfizer’s board, Reagan-Udall, Kyowa Kirin, Assembly, BioCryst and more

...Ziezula was president and managing director of the Merck KGaA (Xetra:MRK) subsidiary EMD Serono Inc. Assembly Biosciences Inc....
...Mackison as CBO, a new position. He was SVP of corporate development and strategy at Assembly Biosciences Inc....
...He was director of rare disease development at Orion Corp. (HSE:ORNAV; HSE:ORNBV). Robin Sawka, BioCentury Staff Locana Inc. Assembly Biosciences Inc. BrainStorm...
BioCentury | Dec 12, 2019
Financial News

Trio of follow-ons lift 2019 tally of deals

...At least three other companies--Forty Seven Inc. (NASDAQ:FTSV) and Momenta Pharmaceuticals Inc. (NASDAQ:MNTA) and Assembly Biosciences Inc....
BioCentury | Dec 12, 2019
Financial News

Momenta, Forty Seven, Assembly push 2019 follow-on tally to $21.5B

...myelogenous leukemia (AML) (see “Magrolimab Data in MDS, AML Raise Bar for anti-CD47s”). Microbiome company Assembly Biosciences Inc....
...Assembly gained $6.10 (34%) Thursday to close at $23.81. Val Kennedy, Associate Editor Momenta Pharmaceuticals Inc. Forty Seven Inc. Assembly Biosciences Inc....
BioCentury | Nov 9, 2019
Company News

Management tracks: Teva, Ipsen, ADC, Assembly, Kaleido, Biodesix, CorMedix, Ideaya, Partner, Neurana, Odylia and T1D Exchange

...conjugate company. Herron was EVP and chief commercial officer at ImmunoGen Inc. (NASDAQ:IMGN). HBV company Assembly Biosciences Inc....
...interim role in April. Jonathan Block, Associate Editor ADC Therapeutics S.A. Relay Therapeutics Inc. Biodesix Inc. Kaleido Biosciences Inc. Neurana Pharmaceuticals Inc. Assembly Biosciences Inc. Partner...
BioCentury | Oct 30, 2019
Company News

Management tracks: Vectura, Editas, Assembly, Camp4, Tempus, Passage Bio, Boundless Bio and Prometheus

...at the EMD Serono Inc. division of Merck KGaA (Xetra:MRK). HBV and microbiome-associated disease company Assembly Biosciences Inc....
...Inc. subsidiary of Cosmo Pharmaceuticals N.V. (SIX:COPN). Jonathan Block, Associate Editor Tempus Labs Inc. Vectura Group plc Editas Medicine Inc. Assembly Biosciences Inc. Camp4...
BioCentury | Aug 7, 2019
Company News

Management tracks: Gilead's McHutchison joins Assembly as CEO; plus Lilly, Vor, HiberCell, insitro and more

...Asymmetry Capital Management and previously served as founding partner at Endurant Capital Management. BioCentury Staff Amneal Pharmaceuticals Inc. Assembly Biosciences Inc. Eli...
Items per page:
1 - 10 of 41
BioCentury | Jul 28, 2020
Emerging Company Profile

Frazier, Marcadia founders reunite for rare endocrine diseases in MBX’s $34.6M A round

...diseases company that DiMarchi co-founded, for undisclosed sums. Other companies the two separately co-founded include Assembly Biosciences Inc....
BioCentury | Jul 20, 2020
Deals

Putting cash to work, BeiGene taps Assembly’s HBV program for first non-oncology deal

...through a deal with Assembly that gives it territorial rights to three clinical HBV programs. Assembly Biosciences Inc....
...added $5.28 to $253.95. Targets PARP-1 - Poly(ADP-ribose) polymerase-1 PARP-2 - Poly(ADP-ribose) polymerase-2 Paul Bonanos, Associate Editor ABI-H0731 ABI-H2158 ABI-H3733 Assembly Biosciences Inc. BeiGene...
BioCentury | Jun 23, 2020
Product Development

June 22 Quick Takes: Invitae acquiring ArcherDX; plus lymphoma approval for Karyopharm, Merck, Nabriva, Myovant, Assembly-AbbVie, Genentech and more

...PDUFA date for the GNRHR antagonist is Dec. 20. AbbVie ends microbiome deal with Assembly Assembly Biosciences Inc....
...#), REGN668 (Compound #), dupilumab (Generic), Dupixent (Informal) Merck & Co. Inc. Nabriva Therapeutics AG Myovant Sciences GmbH AbbVie Inc. Assembly Biosciences Inc. Genentech...
BioCentury | May 29, 2020
Management Tracks

Delaney takes over as Assembly’s CSO; plus NGM, TCR2, Amunix, Evox, Vor and more

...as EVP and CFO. She was SVP and CFO of Pfenex Inc. (NYSE-A:PFNX). Robin Sawka, Staff Writer Assembly Biosciences Inc. NGM...
BioCentury | Apr 4, 2020
Management Tracks

CureVac names Stéphenne chairman; plus Desmond-Hellmann to Pfizer’s board, Reagan-Udall, Kyowa Kirin, Assembly, BioCryst and more

...Ziezula was president and managing director of the Merck KGaA (Xetra:MRK) subsidiary EMD Serono Inc. Assembly Biosciences Inc....
...Mackison as CBO, a new position. He was SVP of corporate development and strategy at Assembly Biosciences Inc....
...He was director of rare disease development at Orion Corp. (HSE:ORNAV; HSE:ORNBV). Robin Sawka, BioCentury Staff Locana Inc. Assembly Biosciences Inc. BrainStorm...
BioCentury | Dec 12, 2019
Financial News

Trio of follow-ons lift 2019 tally of deals

...At least three other companies--Forty Seven Inc. (NASDAQ:FTSV) and Momenta Pharmaceuticals Inc. (NASDAQ:MNTA) and Assembly Biosciences Inc....
BioCentury | Dec 12, 2019
Financial News

Momenta, Forty Seven, Assembly push 2019 follow-on tally to $21.5B

...myelogenous leukemia (AML) (see “Magrolimab Data in MDS, AML Raise Bar for anti-CD47s”). Microbiome company Assembly Biosciences Inc....
...Assembly gained $6.10 (34%) Thursday to close at $23.81. Val Kennedy, Associate Editor Momenta Pharmaceuticals Inc. Forty Seven Inc. Assembly Biosciences Inc....
BioCentury | Nov 9, 2019
Company News

Management tracks: Teva, Ipsen, ADC, Assembly, Kaleido, Biodesix, CorMedix, Ideaya, Partner, Neurana, Odylia and T1D Exchange

...conjugate company. Herron was EVP and chief commercial officer at ImmunoGen Inc. (NASDAQ:IMGN). HBV company Assembly Biosciences Inc....
...interim role in April. Jonathan Block, Associate Editor ADC Therapeutics S.A. Relay Therapeutics Inc. Biodesix Inc. Kaleido Biosciences Inc. Neurana Pharmaceuticals Inc. Assembly Biosciences Inc. Partner...
BioCentury | Oct 30, 2019
Company News

Management tracks: Vectura, Editas, Assembly, Camp4, Tempus, Passage Bio, Boundless Bio and Prometheus

...at the EMD Serono Inc. division of Merck KGaA (Xetra:MRK). HBV and microbiome-associated disease company Assembly Biosciences Inc....
...Inc. subsidiary of Cosmo Pharmaceuticals N.V. (SIX:COPN). Jonathan Block, Associate Editor Tempus Labs Inc. Vectura Group plc Editas Medicine Inc. Assembly Biosciences Inc. Camp4...
BioCentury | Aug 7, 2019
Company News

Management tracks: Gilead's McHutchison joins Assembly as CEO; plus Lilly, Vor, HiberCell, insitro and more

...Asymmetry Capital Management and previously served as founding partner at Endurant Capital Management. BioCentury Staff Amneal Pharmaceuticals Inc. Assembly Biosciences Inc. Eli...
Items per page:
1 - 10 of 41